These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9200765)

  • 1. Special considerations for monitoring vancomycin concentrations in pediatric patients.
    Miles MV; Li L; Lakkis H; Youngblood J; McGinnis P
    Ther Drug Monit; 1997 Jun; 19(3):265-70. PubMed ID: 9200765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
    Durham SH; Simmons ML; Mulherin DW; Foland JA
    Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
    Madigan T; Sieve RM; Graner KK; Banerjee R
    Pharmacotherapy; 2013 Dec; 33(12):1264-72. PubMed ID: 23864541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML; Cole E; Wolfsdorf J
    J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.
    Durham SH; Garza KB; Eiland LS
    Am J Health Syst Pharm; 2016 Jul; 73(13):969-74. PubMed ID: 27325878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
    Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
    Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
    Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Antibiotic Stewardship: Optimization of Vancomycin Therapy Based on Individual Pharmacokinetics.
    Kreitmeyr K; Pecar A; Mikolajczyk R; von Both U; Huebner J
    Pediatr Infect Dis J; 2021 Jun; 40(6):556-562. PubMed ID: 33956756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine monitoring of gentamicin serum concentrations in pediatric patients with normal renal function is unnecessary.
    Logsdon BA; Phelps SJ
    Ann Pharmacother; 1997 Dec; 31(12):1514-8. PubMed ID: 9416390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children.
    Gordon CL; Thompson C; Carapetis JR; Turnidge J; Kilburn C; Currie BJ
    Pediatr Infect Dis J; 2012 Dec; 31(12):1269-71. PubMed ID: 22828642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.